Related Experiment Video

Updated: Jun 26, 2026

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
04:53

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

Conducting clinical trials in pediatrics

Duncan Macrae1

  • 1Royal Brompton Hospital, London, United Kingdom. d.macrae@rbht.nhs.uk

Critical Care Medicine
|December 24, 2008
PubMed

Insights

Pediatric critical care clinical trials face challenges but are vital for new treatments. Innovative designs and collaborations, with patient/parent input, are key to improving child health outcomes.

Area of Science:

  • Pediatric Critical Care Medicine
  • Clinical Trial Design
  • Medical Research Ethics

Background:

  • Clinical trials in pediatric critical care are essential for advancing treatment strategies and improving patient outcomes.
  • Significant challenges exist for clinicians, parents, and child participants in pediatric critical care research.
  • Permitting adult treatment "trickle down" without pediatric-specific trials poses risks to children.

Purpose of the Study:

  • To highlight the necessity of pediatric clinical trials.
  • To address the challenges in conducting these trials.
  • To advocate for innovative approaches and collaborative efforts.

Main Methods:

  • Review of existing challenges in pediatric critical care research.
  • Discussion of the limitations of traditional trial outcomes (e.g., mortality).
  • Emphasis on the development of innovative trial designs and collaborative research models.

Main Results:

  • Pediatric critical care populations are small, and low mortality rates limit the use of mortality as a primary outcome.
  • Innovative trial designs incorporating nonfatal outcomes are being developed.
  • Effective research collaborations are crucial for commissioning and supervising pediatric trials.

Conclusions:

  • Pediatric clinical trials are crucial for child health, despite inherent difficulties.
  • Innovative trial designs and collaborative research are essential for success.
  • Involving children and parents in trial development is highly recommended and valued.

More Related Videos

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia10:49

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Published on: September 18, 2013

Related Concept Videos

Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Preclinical Development: Overview01:28

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...